NEWS DETAIL

关于儿科研究计划 (PIP) 的意见/决定：Jyseleca，马来酸菲戈替尼，决定类型：PM：关于修改已商定 PIP 申请的决定，治疗领域：肌肉骨骼和结缔组织疾病，PIP 编号：EMA/PE/0000232302

Alfasigma S.p.A.

医药资讯 July 2, 2026

正文内容

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Produtos relacionados com este artigo

Estes produtos foram associados automaticamente a partir do titulo, resumo e conteudo do artigo.

Perguntas frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Compre online.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.